RSCM
BPMC

Rock Springs Capital Management’s Blueprint Medicines BPMC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$23.8M Sell
185,500
-822,069
-82% -$105M 1.48% 26
2025
Q1
$89.2M Sell
1,007,569
-89,330
-8% -$7.91M 5.1% 3
2024
Q4
$95.7M Buy
1,096,899
+328,123
+43% +$28.6M 3.64% 5
2024
Q3
$71.1M Sell
768,776
-1,691,641
-69% -$156M 2.31% 8
2024
Q2
$265M Sell
2,460,417
-38,031
-2% -$4.1M 7.98% 1
2024
Q1
$237M Sell
2,498,448
-383,119
-13% -$36.3M 6.02% 1
2023
Q4
$266M Buy
2,881,567
+196,273
+7% +$18.1M 6.54% 1
2023
Q3
$135M Buy
2,685,294
+498,622
+23% +$25M 3.61% 5
2023
Q2
$138M Buy
2,186,672
+153,624
+8% +$9.71M 3.29% 5
2023
Q1
$91.5M Buy
2,033,048
+141,538
+7% +$6.37M 2.18% 12
2022
Q4
$82.9M Buy
1,891,510
+353,315
+23% +$15.5M 1.99% 15
2022
Q3
$101M Buy
1,538,195
+559,021
+57% +$36.8M 2.62% 9
2022
Q2
$49.5M Buy
979,174
+31,459
+3% +$1.59M 1.44% 23
2022
Q1
$60.5M Buy
947,715
+87,960
+10% +$5.62M 1.52% 21
2021
Q4
$92.1M Buy
859,755
+10,096
+1% +$1.08M 2.13% 11
2021
Q3
$87.4M Buy
849,659
+40,799
+5% +$4.19M 1.84% 15
2021
Q2
$71.1M Buy
808,860
+62,128
+8% +$5.46M 1.41% 18
2021
Q1
$72.6M Sell
746,732
-95,268
-11% -$9.26M 1.58% 20
2020
Q4
$94.4M Sell
842,000
-110,773
-12% -$12.4M 2% 8
2020
Q3
$88.3M Sell
952,773
-7,256
-0.8% -$673K 2.24% 6
2020
Q2
$74.9M Buy
960,029
+223,029
+30% +$17.4M 2.05% 5
2020
Q1
$43.1M Buy
737,000
+355,000
+93% +$20.8M 1.78% 13
2019
Q4
$30.6M Buy
382,000
+48,500
+15% +$3.89M 0.97% 38
2019
Q3
$24.5M Buy
333,500
+26,000
+8% +$1.91M 0.98% 34
2019
Q2
$29M Buy
307,500
+32,500
+12% +$3.07M 1.05% 30
2019
Q1
$22M Buy
275,000
+61,342
+29% +$4.91M 0.85% 40
2018
Q4
$11.5M Buy
213,658
+13,658
+7% +$736K 0.54% 59
2018
Q3
$15.6M Buy
200,000
+1,000
+0.5% +$78.1K 0.57% 62
2018
Q2
$12.6M Buy
199,000
+41,247
+26% +$2.62M 0.49% 71
2018
Q1
$14.5M Buy
157,753
+11,253
+8% +$1.03M 0.62% 62
2017
Q4
$11M Buy
146,500
+60,000
+69% +$4.52M 0.5% 71
2017
Q3
$6.03M Buy
+86,500
New +$6.03M 0.28% 96